Quantcast

Latest Vaccination Stories

2014-06-04 23:07:10

The urgent care provider hopes to protect South Floridians from the record number of measles cases predicted for 2014. West Palm Beach, FL (PRWEB) June 04, 2014 South Florida’s leading urgent care provider, MD Now Urgent Care, has stocked up on the measles vaccine after the Centers for Disease Control (CDC) issued an urgent warning predicting a record number of cases for 2014. MD Now will offer the vaccine to both adults and children at all its locations in Palm Beach, Broward, and...

2014-06-04 12:29:22

ANNAPOLIS, Md., June 4, 2014 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP) announced today that new data from its SparVax(®) anthrax vaccine program were recently presented at the 2014 U.S. Food and Drug Administration (FDA) Medical Countermeasures Initiative (MCMi) Regulatory Science Symposium in Silver Spring, MD. In a presentation entitled, "Recombinant Protective Antigen Vaccine (SparVax(®)) Provides Protection Equivalent to BioThrax(®) Against Lethal Challenge with Bacillus...

2014-05-31 23:09:41

MarketReportsOnline.com adds "Indian Vaccine Industry: Trends & Opportunities (2012-2017)" report to its research store. Dallas, Texas (PRWEB) May 31, 2014 The report titled "Indian Vaccine Industry: Trends and Opportunities (2012-2017) offers in-depth study of the global as well as the Indian vaccine industry with detailed discussion on the major segments of the vaccine industry including rabies, seasonal influenza, polio, hepatitis B, HPV. The report also covers...

2014-05-30 16:23:24

TAMPA, Fla., May 30, 2014 /PRNewswire/ -- Drs. Michael J.P. Lawman and Patricia D. Lawman, founders of the Tampa-based biotech firm Morphogenesis Inc., announce the publication of "Cancer Vaccines: Methods and Protocols," the most definitive work to date in the promising field of cancer vaccines. As co-editors, the Lawmans worked for two-and-a-half years with leading cancer researchers, physicians, educators and subject matter experts from around the world to gather, catalogue and...

2014-05-30 12:26:02

MERIDEN, Conn., May 30, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that Astellas Pharma has submitted an application for marketing approval of recombinant influenza HA vaccine ASP7374 (marketed as Flublok® in the United States by Protein Sciences) to the Ministry of Health, Labour and Welfare in Japan for the prevention of influenza. UMN Pharma, which is partnered with Astellas, holds an exclusive license from Protein Sciences for the development and marketing...

2014-05-30 04:22:21

BLUE BELL, Pa., May 30, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its previously announced 1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014. The common stock will continue to trade under the symbol "INO." As filed on May 22, 2014, the Company's stockholders approved the proposal of a reverse...

2014-05-29 16:26:48

WASHINGTON, May 29, 2014 /PRNewswire-USNewswire/ -- The PATH Malaria Vaccine Initiative (MVI) announced today that C. Richter (Rick) King, PhD, has been named Director of Research & Development (R&D). MVI drives the development of safe and effective vaccines to combat malaria. Malaria still kills more than 600,000 people worldwide, and half the world's population remains at risk of contracting the disease. Dr. King is an accomplished scientist with more than 25 years of...

2014-05-29 12:28:35

ANNAPOLIS, Md., May 29, 2014 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP) announced today that new analytical data from the Company's SparVax(®) anthrax vaccine program were presented at the 114(th) General Meeting of the American Society for Microbiology (ASM), held recently in Boston, Massachusetts. In a poster presentation entitled "Evidence Correlating Changes in Structure and Biological Activity for a Recombinant Protective Antigen (rPA) Anthrax Vaccine," Dr. Bradford Powell,...

2014-05-27 23:10:19

“Only 24% of (Hispanic male) participants believed that the HPV vaccine could prevent future problems, and 53% said they would not be vaccinate,” according to the Journal of Transcultural Nursing from May 19, 2014 (1). polyDNA reviews the study and recommends Gene-Eden-VIR and Novirin to help the immune systems target the latent human papillomavirus. Rochester, NY (PRWEB) May 27, 2014 A new study reported the attitudes of Hispanic men regarding HPV vaccination. Researchers learned...

2014-05-27 11:33:01

Canadian Medical Association Journal Employers planning to implement mandatory influenza vaccination policies for health care workers need to understand the implications, according to an analysis published in CMAJ (Canadian Medical Association Journal). Vaccination rates among health care workers are less than 50%, well below the level necessary for herd immunity. Evidence indicates that vaccination of health care workers can benefit patient health, leading to a move by many to...


Latest Vaccination Reference Libraries

0_ac8af9115d7f37daaaa2af4dba273fb1
2011-01-11 14:17:29

The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...

More Articles (1 articles) »
Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related